ALSGD — Spineguard SA Share News
0.000.00%
Last trade - 00:00- €8.25m
- €8.96m
- €3.76m
French medical device maker SpineGuard's H1 loss widens on US sales model shift
Brief: SpineGuard H1 Sales EUR 1.449 Million
France's SpineGuard H1 revenue falls 32% on US business model shift
France's SpineGuard 2025 revenue falls 19% on business model transformation
France's SpineGuard FY 2025 revenue falls 19% amid cost structure adaptation
Brief: SpineGuard H1 EBITDA EUR -439 Thousand
Brief: Spineguard Posts H1 Sales EUR 2.12 Mln
Brief: Spineguard Q3 Revenue At 0.98 Mln Euros
Brief: Spineguard Sales Down At EUR 2.2 Mln
Brief: Spineguard H1 Revenue Down At Eur 2.2 Mln
Brief: Spineguard Secures EUR 7.5 Million Equity Line With Nice & Green
Brief: SpineGuard Q4 Revenue Up By 37% At 1.6 Mln Euros
Brief: Spineguard Q3 Revenue Up 44% At 1.5 Million Euros
Brief: Spineguard H1 Net Loss Widens To Eur 1.2 Million
Brief: Spineguard, Omnia Medical Sign Deal For Adult Spine Surgery In U.S.
Brief: Spineguard H1 Revenue Up To EUR 2.5 Mln
Brief: SpineGuard Announces New Partnership With Sorbonne, CNRS And Inserm
Brief: Spineguard FY Revenue Down At Eur 4.4 Million
Brief: Spineguard's Patent Application On DSG-Enabled Robotic Surgery Allowed In The U.S